Mason Street Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-20,395
| Closed | -$268K | – | 1234 |
|
|
2020
Q4 | $268K | Sell |
20,395
-109
| -0.5% | -$1.43K | ﹤0.01% | 1353 |
|
|
2020
Q3 | $198K | Buy |
20,504
+140
| +0.7% | +$1.35K | ﹤0.01% | 1351 |
|
|
2020
Q2 | $233K | Buy |
20,364
+1,786
| +10% | +$20.4K | ﹤0.01% | 1298 |
|
|
2020
Q1 | $192K | Hold |
18,578
| – | – | ﹤0.01% | 1285 |
|
|
2019
Q4 | $305K | Buy |
18,578
+489
| +3% | +$8.03K | 0.01% | 1279 |
|
|
2019
Q3 | $240K | Buy |
18,089
+410
| +2% | +$5.44K | ﹤0.01% | 1322 |
|
|
2019
Q2 | $249K | Buy |
17,679
+772
| +5% | +$10.9K | 0.01% | 1303 |
|
|
2019
Q1 | $311K | Buy |
16,907
+619
| +4% | +$11.4K | 0.01% | 1286 |
|
|
2018
Q4 | $426K | Buy |
16,288
+811
| +5% | +$21.2K | 0.01% | 1088 |
|
|
2018
Q3 | $355K | Buy |
+15,477
| New | +$355K | 0.01% | 1215 |
|